About meI'm a private investor running concentrated investment strategy focused on emerging, venture stage public and private companies. Follow my journey at http://DTM5.com
RVPH is within 8 weeks of reporting expected positive P3 results on a drug compound with blockbuster potential.
A great setup - Beautiful triangle formation is complete with a strong base. 200 day MA is easily within range.
NBVA / NBVAF - Nubeva Technologies - has patented a solution to ransomware. It is an endpoint software - easily and inexpensively deployable - that intercepts and enables fast, inexpensive and complete reversal of ransomware infection. It has been tested extensively and validated by third parties. Sales numbers may ramp exponentially over the next several...
